Mealey's (January 8, 2019, 10:25 AM EST) -- BROOKLYN, N.Y. — A New York state court justice on Dec. 20 dismissed a negligence claim against Actavis Pharma Inc., finding that the generic drug maker’s duties to monitor prescribing of its oxycodone opioid drug do not extend to a plaintiff who claims that he became addicted to oxycodone (Alvin Floyd v. Lazar Feygin, M.D., No. 507458/17, N.Y. Sup., Kings Co., 2018 NYLJ LEXIS 4206)....